Kilitch Drugs (India) share news, announcements and annual reports
NSE: KILITCHBSE: 524500Pharmaceuticals & BiotechnologySmall Cap
Kilitch Drugs (India) Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Sep 2010 on NSE
Last close ₹201.32down ₹7.82 (3.74%)BSE ₹201.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹209.14.
30 Oct: open ₹211.45, high ₹212.24, low ₹200.25
52-week range of traded prices to 30 Oct 2026
₹117.25Low, 30 Mar 2026₹267.90High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹704 Cr1,776th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.42
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.52
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 12.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 8.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.32
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 34,67341.3% delivered
Kilitch Drugs (India) board meetings
156 filed, newest first. Page 4 of 4.
Aug 2011
4 Aug · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended June 30, 2011; (2) Any other matter with the permission of the Chair.
Jul 2011
18 Jul · Board meeting
(1) To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2011; (2) To recommend dividend on equity shares of the Company subject to approval of the members at the ensuing Annual General Meeting; (3) To adopt and approve the Notice & Directors Report of the Company along with the Corporate Governance Report for financial year 2010-11; (4) To finalize the dates of Book Closure for the purpose of forthcoming Annual General Meeting and dividend; (5) To finalize the date, venue and time for convening Annual General Meeting of the Members of the Company; (6) Any other matter with the permission of the Chair.
May 2011
5 May · Board meeting
To transact the following business : (1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended March 31, 2011; (2) Any other matter with the permission of the Chair.
Feb 2011
2 Feb · Board meeting
(1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended December 31,2010. (2) To consider allotment of shares against exercise of employee stock option under ESOS KDL 2007 as approved by the shareholders of the Company at their Extra Ordinary General Meeting held on May 31, 2010.
Oct 2010
28 Oct · Board meeting
1) To take on record the Unaudited (Provisional) Financial Results for the Quarter ended September 30, 2010; 2) Any other matter with the permission of the Chair.11 Oct · Board meeting
1) To consider allotment of shares against exercise of employee stock option under ESOS KDL 2007 as approved by the shareholders of the Company at their Extra Ordinary General Meeting held on May 31, 2010. 2)Any other matter with the permission of the Chair.